Physicians Likely To Support Portola's Betrixaban
December 27, 2016 at 12:07 PM EST
Morgan Stanley is bullish on Portola Pharmaceuticals Inc (NASDAQ: PTLA) following the FDA acceptance of betrixaban for priority review. ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.